HSE has published extensively revised guidance on managing bloodborne virus (BBV) hazards in workplaces. The guidance has been refreshed following feedback from the National AIDS Trust and other topic experts. It will help employers identify if BBV hazards exist in their workplace and provides practical tips on risk assessment. The updated guidance also: outlines simple preventative measures explains actions to…
Ben KempMay 9, 2025
Wednesday, May 21, 2025 | 9:00 AM 10:00 AM CST Join our subject matter experts, Allison Strochlic, Senior Research Director, Andrea Sutton, Research Director, and Petra Boeree, Lead Human Factors Specialist from Emergo by UL’s Human Factors Research & Design team on May 21, 2025 from 9:00 – 10:00 a.m. CST as they hold an open forum to answer your…
Ben KempMay 9, 2025
New rules for businesses in Britain posting parcels to Northern Ireland have come into effect. The changes are a consequence of Northern Ireland's post-Brexit deal known as the Windsor Framework. The major change is for business-to-business parcels which now require customs declarations. Parcel companies need to be signed up to a trusted trader scheme but individuals posting and receiving parcels should…
Ben KempMay 9, 2025
NHS England (NHSE) has published new guidance setting out how clinical digital systems can support optimal antimicrobial stewardship (AMS) within healthcare organisations BSAC welcomes this important development and looks forward to seeing how this vision will be translated into Trust-level work plans that are properly resourced and coordinated. BSAC also acknowledges this guidance will be useful, and should be…
Ben KempMay 8, 2025
The UK Health Security Agency (UKHSA) is excited to announce the availability of its innovative X-ray irradiated pathogen reagents service, offering a unique solution to one of the most significant challenges facing scientists today: safe access to high-consequence pathogens. Overcoming Containment Barriers in Diagnostic Development Working with high-risk pathogens typically requires specialised containment facilities (Hazard Group 3 or 4), which…
Ben KempMay 8, 2025
The UK 2024 - 2029 National Action Plan on AMR was released on 8th May 2024 — so what progress has been made in a year? While progress has been made in some areas, namely reduced antibiotic usage in agriculture and the launch of the 'Netflix-style' antibiotics subscription model, efforts to utilise diagnostics have been lacking. Four years still remain…
Ben KempMay 6, 2025
After years of negotiations, the landmark UK-India trade deal has been finalised. For our industry, we welcome the reduction of tariffs and rules of origin on medical devices, making it easier for BIVDA members to export to India, and access to billions of pounds worth of tenders for UK companies. Indian tariffs will now be slashed across the board, locking…
Ben KempMay 6, 2025